Healthcare News: Healthcare Latest News, Healthcare Today news, Healthcare Breaking News

Novo Nordisk’s Bold Price Cuts Spark 70% Sales Surge for Wegovy Amid India’s Generic Semaglutide Explosion

Sales of weight-loss drug Wegovy soars 70% after steep price cuts in April

‘Technology can reveal risks at a scale no human system can match’: Sangita Reddy, Joint Managing Director, Apollo Hospitals

Apollo Hospitals’ Sangita Reddy outlines a pivot from episodic to continuous healthcare, leveraging AI and digital tools to detect early-onset…

May 2, 2026 01:00 IST

India’s Lord’s Mark Secures Rare Global Nod for HIV Self-Test Production

India’s Lord’s Mark secures global nod for HIV self-test

Lord’s Mark Industries has received Central Licensing Authority approval to manufacture the LordsMed HIV 1&2 Self Test.

May 2, 2026 00:48 IST

Dr. Reddy’s gets nod for generic Semaglutide in Canada

Dr. Reddy’s Laboratories (DRL) has secured Health Canada’s first-ever generic Semaglutide approval, targeting the world’s second-largest market for the diabetes…

Updated: April 29, 2026 19:43 IST

Ganesh Nathella is EVP & GM, healthcare and lifesciences business, Persistent Systems

Scaling care the smart way

Healthcare is moving from digital adoption to intelligence adoption. By integrating AI into clinical, operational, and administrative workflows, providers are…

April 16, 2026 00:53 IST

India’s Pharma Market Hits ₹2.46 Lakh Crore: GLP-1 Surge and Price Hikes Drive 8.8% Growth in FY26

Domestic pharma grew at 8.8% in FY26; Torrent, Cipla surge ahead in the Rs 2.46 lakh crore market

The Indian domestic pharmaceutical market grew to ₹2.46 lakh crore in FY26, fueled by a 13.6% jump in the cardiac…

April 12, 2026 18:18 IST

Novo’s Semaglutide Snatches Market Share as Eli Lilly’s Mounjaro Sales Plunge 21%

Mounjaro takes a hit as generic weight-loss medicines flood the market

The expiration of Novo Nordisk’s semaglutide patent on March 20, 2026, has triggered a massive shift in India’s ₹1,600 crore…

April 10, 2026 00:13 IST

Emcure Slashes Semaglutide Price by 55% to ₹999 per Week

Emcure cuts GLP drug Poviztra price by 55%

Emcure Pharmaceuticals has announced a massive 55% price cut for Poviztra, its semaglutide weight-management drug in India.

April 3, 2026 01:15 IST

CII Urges Government to Shield Pharma Sector from West Asia Conflict Impact

Industry body seeks govt aid to tide over disruptions in the pharma and MedTech sectors

The Confederation of Indian Industry (CII) has petitioned the Department of Pharmaceuticals for freight subsidies and drug pricing relaxations as…

April 1, 2026 21:12 IST

CureMeAbroad: The ‘Booking.com’ for Medical Tourism Disrupting the $130 Billion Global Healthcare Market

CureMeAbroad building global medical tourism platform

Pune-based startup CureMeAbroad is revolutionizing medical tourism with an AI-driven discovery platform for high-value patients from the US, UK, and…

March 26, 2026 21:31 IST

Healthcare Providers Hedge Against West Asia War as MedTech Reels from 50% Cost Spike

Healthcare sector remains largely unaffected by the West Asia war: Industry body NATHEALTH

While NATHEALTH reports a stable outlook for Indian hospitals amid the West Asia conflict, medical device manufacturers (AiMeD) are seeking…

March 25, 2026 20:37 IST

How the Ras Laffan Shutdown and Helium Scarcity are Rattling Indian Healthcare

War impact: Supply snarls hit liquid helium used in MRI scanners & for chip-making

While NATHEALTH leaders highlight a $1 trillion opportunity in raising India’s Health-Adjusted Life Expectancy (HALE), the industry must first navigate…

March 25, 2026 18:38 IST

Dr Anirban Deep Banerjee, director, neurosurgery, Medanta Gurugram

The brain’s new beat

Medanta enhances neurological care with advanced ‘Brain Pacemaker’ surgery

March 21, 2026 21:22 IST

Indian Pharma Giants Launch Affordable Generic Semaglutide for Diabetes and Weight Loss

Indian pharma giants launch low-cost generic semaglutide injections

Following the patent expiry of semaglutide in India, leading pharma companies including Sun Pharma, Dr Reddy’s, Zydus, and Glenmark have…

March 21, 2026 19:38 IST

Local Pharma Giants Slash Semaglutide Prices by 90% After Patent Expiry

Weight-loss drug prices down 70-90% as generics hit the shelves

Following the patent expiry of Novo Nordisk’s semaglutide on March 20, 2026, Indian drugmakers including Natco, Dr. Reddy’s, and Eris…

Updated: March 21, 2026 12:11 IST

Govt defers proposal to include free drugs under CSR rules

The Drugs Technical Advisory Board (DTAB) has deferred a proposal to mandate pharmaceutical companies to contribute 1% of profits to…

March 11, 2026 19:58 IST

India’s Private Hospitals Set for 15% Revenue Surge in FY27 as Specialty Care and Bed Counts Rise

Strong demand, rise in complex treatments, GST exemption on health insurance to drive 15% growth in private hospitals: Crisil

India’s private hospital sector is projected to maintain double-digit growth for the fifth year, with 15% revenue growth expected in…

February 27, 2026 20:31 IST

Healthcare